Pharmedium Recalls Morphine Sulfate Syringes Due to Stability Data Concerns
Pharmedium Services, LLC is recalling 935 syringes of morphine sulfate because stability data does not support the expiry dates, posing a risk of reduced potency.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, if the agency's own classification is FDA Class I or USDA Class I, the score is never below 4; however, FDA Class II with potential loss of potency in a potent opioid medication is treated as Severe (4) due to the significant risk of therapeutic failure or adverse health consequences, aligning with the 'Severe' criteria for significant injury/property-damage reports or high-risk scenarios.
Plain-English summary
Pharmedium Services, LLC is recalling 935 syringes of morphine sulfate, 0.5 mg per mL, in 0.9% sodium chloride, preservative free, 1 mL total volume, for IV use. The recall is being conducted because stability data does not support the expiry dates for the drugs packaged and stored in syringes.
The affected product is identified by product code 2R3119 and specific lot numbers with expiration dates between July 15, 2015, and October 12, 2015. The recall is classified as Class II by the FDA, indicating a situation that might cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the affected syringes and contact Pharmedium Services, LLC for further instructions or replacement. The recall is distributed nationwide.
The recalled product
- Product
- morphine Sulfate, 0.5 mg per mL, in 0.9% Sodium Chloride, Preservative Free, 1 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3119.
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable Medication
- Affected units
- 935
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot Numbers: 15117038M
- 151200111M
- 15126052M
- 15127038M
- 15131015M
- 15134028M
- 15134031M
- 15135049M
- 151380104M
- 15139033M
- 15139063M
- 151410121M
- 15146038M
- 15147041M
- 15149045M
- 15152036M
- 151730212M
- 151890291M
- 151930131M
- Exp between 07/15/15-10/12/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 69 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 69 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
Same hazard · loss of potency
See all →- ModerateInfuvite Adult Multiple Vitamins Injection Recalled Due to Cold Chain Failure
FDA (Drugs) · 2025-05-07
- ModerateCardinal Health Recalls Cyanocobalamin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateSmiths Medical Recalls Arterial Blood Sampling Kits with Povidone Iodine Pads
FDA (Devices) · 2019-02-27
- ModerateBiomerieux Recalls VITEK 2 Gram Negative Susceptibility Cards Due to Moisture Risk
FDA (Devices) · 2017-06-21
- ModerateBiomerieux Recalls VITEK 2 Gram Negative Susceptibility Cards
FDA (Devices) · 2017-06-21